发明名称 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
摘要 The present invention relates to a compound formula [I] wherein R1 and R<SUP>5 </SUP>are each independently hydrogen, halogen, lower alkyl, etc., R<SUP>2 </SUP>is hydrogen or an amino protective group, x is bond, -o-o, -O-CH<SUB>2</SUB>-, etc., y is in which Z is bond, -O-(CH<SUB>2</SUB>)<SUB>m</SUB>- (in which m is 1 to 4), etc., R<SUP>3 </SUP>is lower alkanoyl, carboxy, lower alkoxycarbonyl, etc., and R<SUP>4 </SUP>is hydrogen, halogen, hydroxy, phenoxy, lower alkyl, lower alkoxy, etc., and n is 0, 1 or 2, or a salt thereof. The compound [I] of the present invention and pharmaceutically acceptable salts thereof are useful for the prophylactic and/or the therapeutic treatment of pollakiurea or urinary incontinence.
申请公布号 US2005090669(A1) 申请公布日期 2005.04.28
申请号 US20040504990 申请日期 2004.08.19
申请人 HATTORI KOUJI;TOMISHIMA YASUYO;NAKAJIMA YUTAKA;IMANISHI MASASHI 发明人 HATTORI KOUJI;TOMISHIMA YASUYO;NAKAJIMA YUTAKA;IMANISHI MASASHI
分类号 C07D295/14;A61K31/18;A61K31/196;A61K31/24;A61K31/245;A61K31/27;A61K31/275;A61K31/341;A61K31/351;A61K31/381;A61K31/402;A61K31/44;A61K31/4406;A61K31/4439;A61K31/445;A61K31/455;A61K31/4965;A61K31/695;A61P1/04;A61P1/16;A61P1/18;A61P3/04;A61P3/06;A61P3/10;A61P5/24;A61P9/10;A61P9/12;A61P13/02;A61P13/04;A61P13/08;A61P13/10;A61P15/00;A61P15/06;A61P25/00;A61P25/02;A61P25/22;A61P25/24;A61P27/06;A61P29/00;C07C217/74;C07C219/26;C07C229/46;C07C229/50;C07C229/60;C07C229/64;C07C233/54;C07C233/55;C07C255/57;C07C255/59;C07C271/24;C07C271/28;C07C275/42;C07C311/08;C07C311/35;C07C311/37;C07C311/51;C07C317/44;C07C321/30;C07C323/62;C07D207/26;C07D207/27;C07D211/60;C07D211/62;C07D213/36;C07D213/38;C07D213/40;C07D213/61;C07D213/64;C07D213/643;C07D213/79;C07D213/80;C07D241/24;C07D307/54;C07D307/68;C07D309/12;C07D309/14;C07D333/22;C07D333/32;C07D333/38;C07D333/40;C07D401/04;C07D405/12;C07F7/18;(IPC1-7):C07D49/14;C07D43/14;C07D41/14 主分类号 C07D295/14
代理机构 代理人
主权项
地址